The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drug Delivery Technologies Market Research Report 2025
Synopsis
The global Drug Delivery Technologies market was valued at US$ 763970 million in 2023 and is anticipated to reach US$ 1133150 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Technologies.
Report Scope
The Drug Delivery Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi
Segment by Type
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Segment by Application
Hospitals
Home Care Settings
Clinics
Diagnostic Centres
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Drug Delivery Technologies market was valued at US$ 763970 million in 2023 and is anticipated to reach US$ 1133150 million by 2030, witnessing a CAGR of 5.7% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Delivery Technologies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Delivery Technologies.
Report Scope
The Drug Delivery Technologies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug Delivery Technologies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Delivery Technologies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson Services
Novartis
Roche
Pfizer
Bayer
Antares Pharma
Becton Dickinson
GlaxoSmithKline
Kindeva
Merck
Sanofi
Segment by Type
Oral Drug Delivery
Pulmonary Drug Delivery
Injectable Drug Delivery
Ocular Drug Delivery
Nasal Drug Delivery
Topical Drug Delivery
Implantable Drug Delivery
Transmucosal Drug Delivery
Segment by Application
Hospitals
Home Care Settings
Clinics
Diagnostic Centres
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Delivery Technologies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Delivery Technologies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Drug Delivery
1.2.3 Pulmonary Drug Delivery
1.2.4 Injectable Drug Delivery
1.2.5 Ocular Drug Delivery
1.2.6 Nasal Drug Delivery
1.2.7 Topical Drug Delivery
1.2.8 Implantable Drug Delivery
1.2.9 Transmucosal Drug Delivery
1.3 Market by Application
1.3.1 Global Drug Delivery Technologies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Home Care Settings
1.3.4 Clinics
1.3.5 Diagnostic Centres
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Delivery Technologies Market Perspective (2019-2030)
2.2 Drug Delivery Technologies Growth Trends by Region
2.2.1 Global Drug Delivery Technologies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Delivery Technologies Historic Market Size by Region (2019-2024)
2.2.3 Drug Delivery Technologies Forecasted Market Size by Region (2025-2030)
2.3 Drug Delivery Technologies Market Dynamics
2.3.1 Drug Delivery Technologies Industry Trends
2.3.2 Drug Delivery Technologies Market Drivers
2.3.3 Drug Delivery Technologies Market Challenges
2.3.4 Drug Delivery Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Delivery Technologies Players by Revenue
3.1.1 Global Top Drug Delivery Technologies Players by Revenue (2019-2024)
3.1.2 Global Drug Delivery Technologies Revenue Market Share by Players (2019-2024)
3.2 Global Drug Delivery Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Delivery Technologies Revenue
3.4 Global Drug Delivery Technologies Market Concentration Ratio
3.4.1 Global Drug Delivery Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Delivery Technologies Revenue in 2023
3.5 Drug Delivery Technologies Key Players Head office and Area Served
3.6 Key Players Drug Delivery Technologies Product Solution and Service
3.7 Date of Enter into Drug Delivery Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Delivery Technologies Breakdown Data by Type
4.1 Global Drug Delivery Technologies Historic Market Size by Type (2019-2024)
4.2 Global Drug Delivery Technologies Forecasted Market Size by Type (2025-2030)
5 Drug Delivery Technologies Breakdown Data by Application
5.1 Global Drug Delivery Technologies Historic Market Size by Application (2019-2024)
5.2 Global Drug Delivery Technologies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Delivery Technologies Market Size (2019-2030)
6.2 North America Drug Delivery Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Delivery Technologies Market Size by Country (2019-2024)
6.4 North America Drug Delivery Technologies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Delivery Technologies Market Size (2019-2030)
7.2 Europe Drug Delivery Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Delivery Technologies Market Size by Country (2019-2024)
7.4 Europe Drug Delivery Technologies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Technologies Market Size (2019-2030)
8.2 Asia-Pacific Drug Delivery Technologies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Delivery Technologies Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Delivery Technologies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Delivery Technologies Market Size (2019-2030)
9.2 Latin America Drug Delivery Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Delivery Technologies Market Size by Country (2019-2024)
9.4 Latin America Drug Delivery Technologies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Technologies Market Size (2019-2030)
10.2 Middle East & Africa Drug Delivery Technologies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Delivery Technologies Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Delivery Technologies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson Services
11.1.1 Johnson & Johnson Services Company Detail
11.1.2 Johnson & Johnson Services Business Overview
11.1.3 Johnson & Johnson Services Drug Delivery Technologies Introduction
11.1.4 Johnson & Johnson Services Revenue in Drug Delivery Technologies Business (2019-2024)
11.1.5 Johnson & Johnson Services Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Drug Delivery Technologies Introduction
11.2.4 Novartis Revenue in Drug Delivery Technologies Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Drug Delivery Technologies Introduction
11.3.4 Roche Revenue in Drug Delivery Technologies Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Drug Delivery Technologies Introduction
11.4.4 Pfizer Revenue in Drug Delivery Technologies Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Drug Delivery Technologies Introduction
11.5.4 Bayer Revenue in Drug Delivery Technologies Business (2019-2024)
11.5.5 Bayer Recent Development
11.6 Antares Pharma
11.6.1 Antares Pharma Company Detail
11.6.2 Antares Pharma Business Overview
11.6.3 Antares Pharma Drug Delivery Technologies Introduction
11.6.4 Antares Pharma Revenue in Drug Delivery Technologies Business (2019-2024)
11.6.5 Antares Pharma Recent Development
11.7 Becton Dickinson
11.7.1 Becton Dickinson Company Detail
11.7.2 Becton Dickinson Business Overview
11.7.3 Becton Dickinson Drug Delivery Technologies Introduction
11.7.4 Becton Dickinson Revenue in Drug Delivery Technologies Business (2019-2024)
11.7.5 Becton Dickinson Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Detail
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Drug Delivery Technologies Introduction
11.8.4 GlaxoSmithKline Revenue in Drug Delivery Technologies Business (2019-2024)
11.8.5 GlaxoSmithKline Recent Development
11.9 Kindeva
11.9.1 Kindeva Company Detail
11.9.2 Kindeva Business Overview
11.9.3 Kindeva Drug Delivery Technologies Introduction
11.9.4 Kindeva Revenue in Drug Delivery Technologies Business (2019-2024)
11.9.5 Kindeva Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Drug Delivery Technologies Introduction
11.10.4 Merck Revenue in Drug Delivery Technologies Business (2019-2024)
11.10.5 Merck Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Detail
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Drug Delivery Technologies Introduction
11.11.4 Sanofi Revenue in Drug Delivery Technologies Business (2019-2024)
11.11.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Drug Delivery Technologies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral Drug Delivery
Table 3. Key Players of Pulmonary Drug Delivery
Table 4. Key Players of Injectable Drug Delivery
Table 5. Key Players of Ocular Drug Delivery
Table 6. Key Players of Nasal Drug Delivery
Table 7. Key Players of Topical Drug Delivery
Table 8. Key Players of Implantable Drug Delivery
Table 9. Key Players of Transmucosal Drug Delivery
Table 10. Global Drug Delivery Technologies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Drug Delivery Technologies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Drug Delivery Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Drug Delivery Technologies Market Share by Region (2019-2024)
Table 14. Global Drug Delivery Technologies Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Drug Delivery Technologies Market Share by Region (2025-2030)
Table 16. Drug Delivery Technologies Market Trends
Table 17. Drug Delivery Technologies Market Drivers
Table 18. Drug Delivery Technologies Market Challenges
Table 19. Drug Delivery Technologies Market Restraints
Table 20. Global Drug Delivery Technologies Revenue by Players (2019-2024) & (US$ Million)
Table 21. Global Drug Delivery Technologies Market Share by Players (2019-2024)
Table 22. Global Top Drug Delivery Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Technologies as of 2023)
Table 23. Ranking of Global Top Drug Delivery Technologies Companies by Revenue (US$ Million) in 2023
Table 24. Global 5 Largest Players Market Share by Drug Delivery Technologies Revenue (CR5 and HHI) & (2019-2024)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Drug Delivery Technologies Product Solution and Service
Table 27. Date of Enter into Drug Delivery Technologies Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Drug Delivery Technologies Market Size by Type (2019-2024) & (US$ Million)
Table 30. Global Drug Delivery Technologies Revenue Market Share by Type (2019-2024)
Table 31. Global Drug Delivery Technologies Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 32. Global Drug Delivery Technologies Revenue Market Share by Type (2025-2030)
Table 33. Global Drug Delivery Technologies Market Size by Application (2019-2024) & (US$ Million)
Table 34. Global Drug Delivery Technologies Revenue Market Share by Application (2019-2024)
Table 35. Global Drug Delivery Technologies Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 36. Global Drug Delivery Technologies Revenue Market Share by Application (2025-2030)
Table 37. North America Drug Delivery Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Drug Delivery Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Drug Delivery Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Drug Delivery Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Europe Drug Delivery Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 42. Europe Drug Delivery Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 43. Asia-Pacific Drug Delivery Technologies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 44. Asia-Pacific Drug Delivery Technologies Market Size by Region (2019-2024) & (US$ Million)
Table 45. Asia-Pacific Drug Delivery Technologies Market Size by Region (2025-2030) & (US$ Million)
Table 46. Latin America Drug Delivery Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Latin America Drug Delivery Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 48. Latin America Drug Delivery Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 49. Middle East & Africa Drug Delivery Technologies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 50. Middle East & Africa Drug Delivery Technologies Market Size by Country (2019-2024) & (US$ Million)
Table 51. Middle East & Africa Drug Delivery Technologies Market Size by Country (2025-2030) & (US$ Million)
Table 52. Johnson & Johnson Services Company Detail
Table 53. Johnson & Johnson Services Business Overview
Table 54. Johnson & Johnson Services Drug Delivery Technologies Product
Table 55. Johnson & Johnson Services Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Services Recent Development
Table 57. Novartis Company Detail
Table 58. Novartis Business Overview
Table 59. Novartis Drug Delivery Technologies Product
Table 60. Novartis Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 61. Novartis Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche Drug Delivery Technologies Product
Table 65. Roche Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Drug Delivery Technologies Product
Table 70. Pfizer Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Bayer Company Detail
Table 73. Bayer Business Overview
Table 74. Bayer Drug Delivery Technologies Product
Table 75. Bayer Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 76. Bayer Recent Development
Table 77. Antares Pharma Company Detail
Table 78. Antares Pharma Business Overview
Table 79. Antares Pharma Drug Delivery Technologies Product
Table 80. Antares Pharma Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 81. Antares Pharma Recent Development
Table 82. Becton Dickinson Company Detail
Table 83. Becton Dickinson Business Overview
Table 84. Becton Dickinson Drug Delivery Technologies Product
Table 85. Becton Dickinson Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 86. Becton Dickinson Recent Development
Table 87. GlaxoSmithKline Company Detail
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Drug Delivery Technologies Product
Table 90. GlaxoSmithKline Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Kindeva Company Detail
Table 93. Kindeva Business Overview
Table 94. Kindeva Drug Delivery Technologies Product
Table 95. Kindeva Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 96. Kindeva Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Drug Delivery Technologies Product
Table 100. Merck Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Sanofi Company Detail
Table 103. Sanofi Business Overview
Table 104. Sanofi Drug Delivery Technologies Product
Table 105. Sanofi Revenue in Drug Delivery Technologies Business (2019-2024) & (US$ Million)
Table 106. Sanofi Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug Delivery Technologies Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Drug Delivery Technologies Market Share by Type: 2023 VS 2030
Figure 3. Oral Drug Delivery Features
Figure 4. Pulmonary Drug Delivery Features
Figure 5. Injectable Drug Delivery Features
Figure 6. Ocular Drug Delivery Features
Figure 7. Nasal Drug Delivery Features
Figure 8. Topical Drug Delivery Features
Figure 9. Implantable Drug Delivery Features
Figure 10. Transmucosal Drug Delivery Features
Figure 11. Global Drug Delivery Technologies Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 12. Global Drug Delivery Technologies Market Share by Application: 2023 VS 2030
Figure 13. Hospitals Case Studies
Figure 14. Home Care Settings Case Studies
Figure 15. Clinics Case Studies
Figure 16. Diagnostic Centres Case Studies
Figure 17. Other Case Studies
Figure 18. Drug Delivery Technologies Report Years Considered
Figure 19. Global Drug Delivery Technologies Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 20. Global Drug Delivery Technologies Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 21. Global Drug Delivery Technologies Market Share by Region: 2023 VS 2030
Figure 22. Global Drug Delivery Technologies Market Share by Players in 2023
Figure 23. Global Top Drug Delivery Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Delivery Technologies as of 2023)
Figure 24. The Top 10 and 5 Players Market Share by Drug Delivery Technologies Revenue in 2023
Figure 25. North America Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. North America Drug Delivery Technologies Market Share by Country (2019-2030)
Figure 27. United States Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Canada Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Europe Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Europe Drug Delivery Technologies Market Share by Country (2019-2030)
Figure 31. Germany Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. France Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. U.K. Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Italy Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Russia Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Nordic Countries Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Asia-Pacific Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Asia-Pacific Drug Delivery Technologies Market Share by Region (2019-2030)
Figure 39. China Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Japan Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. South Korea Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Latin America Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Latin America Drug Delivery Technologies Market Share by Country (2019-2030)
Figure 47. Mexico Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Brazil Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Drug Delivery Technologies Market Share by Country (2019-2030)
Figure 51. Turkey Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Drug Delivery Technologies Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Johnson & Johnson Services Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 54. Novartis Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 55. Roche Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 57. Bayer Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 58. Antares Pharma Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 59. Becton Dickinson Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 61. Kindeva Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 62. Merck Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 63. Sanofi Revenue Growth Rate in Drug Delivery Technologies Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
